Experts believe the method could be easily integrated into clinical settings and improve screening for PAD.

The first FDA-cleared AI model of its kind was found to be an accurate screening tool for cardiac amyloidosis.

The new guidelines detail the use of echocardiography to evaluate patients for a variety of conditions.

Statins appear to be the most impactful for patients diagnosed with hypertension or cerebrovascular disease.

New research suggests the technique can effectively break down amyloid fibrinogen microclots, which are believed to interfere with perfusion and cause inflammation.

The photoacoustic CT, or PACT, imaging technique is said to perform comparably to mammography for cancer detection, but without the discomfort of standard mammograms. 

The tool also can be used to predict a person's brain age and risk for a myriad of other chronic conditions as well.

With the software's help, readers are up to three times more accurate and interpretations are nearly twice as fast.